Search

Financial results - MIT & CIPRALEX TRANS SRL

0.00
Financial Summary - Mit & Cipralex Trans Srl
Unique identification code: 37587223
Registration number: J27/505/2017
Nace: 4941
Sales - Ron
125.618
Net Profit - Ron
563
Employees
1
Open Account
Company Mit & Cipralex Trans Srl with Fiscal Code 37587223 recorded a turnover of 2024 of 125.618, with a net profit of 563 and having an average number of employees of 1. The company operates in the field of Transporturi rutiere de mărfuri having the NACE code 4941.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Mit & Cipralex Trans Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 3.475 0 0 39.454 56.154 118.382 107.364 125.618
Total Income - EUR - - 3.475 1.806 0 39.454 56.154 118.382 107.364 125.618
Total Expenses - EUR - - 4.765 5.641 16 31.389 49.491 98.612 104.991 122.509
Gross Profit/Loss - EUR - - -1.289 -3.835 -16 8.064 6.663 19.770 2.373 3.109
Net Profit/Loss - EUR - - -1.332 -3.889 -16 7.721 6.153 18.819 1.596 563
Employees - - 1 0 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 17.7%, from 107.364 euro in the year 2023, to 125.618 euro in 2024. The Net Profit decreased by -1.024 euro, from 1.596 euro in 2023, to 563 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Mit & Cipralex Trans Srl

Rating financiar

Financial Rating -
MIT & CIPRALEX TRANS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Mit & Cipralex Trans Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mit & Cipralex Trans Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Mit & Cipralex Trans Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mit & Cipralex Trans Srl - CUI 37587223

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 5.546 17 0 0 4.969 4.328 2.822 1.322
Current Assets - - 1.410 782 742 12.368 17.282 28.074 17.060 24.476
Inventories - - 0 0 0 0 1.269 0 271 7.021
Receivables - - 1.120 756 742 3.461 7.210 10.729 6.781 8.269
Cash - - 290 25 0 8.907 8.803 17.345 10.009 9.186
Shareholders Funds - - -1.288 -5.154 -5.070 2.746 8.839 21.491 12.526 612
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 8.282 5.952 5.812 9.622 13.413 10.911 7.357 25.186
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4941 - 4941"
CAEN Financial Year 4941
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 24.476 euro in 2024 which includes Inventories of 7.021 euro, Receivables of 8.269 euro and cash availability of 9.186 euro.
The company's Equity was valued at 612 euro, while total Liabilities amounted to 25.186 euro. Equity decreased by -11.844 euro, from 12.526 euro in 2023, to 612 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Mit & Cipralex Trans Srl

Comments - Mit & Cipralex Trans Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.